Foxp3 in control of the regulatory T cell lineage

Nature Immunology

Volumn 8, Issue 5, 2007, Pages 457-462

  Zheng, Ye ^a   Rudensky, Alexander Y ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; GENE MUTATION; HUMAN; IMMUNOPATHOLOGY; INFECTION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FAMILY; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; REVIEW; X CHROMOSOME;

ANIMALS; CELL LINEAGE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 34247277666     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1455     Document Type: Review

References (48)

1. Fontenot, J.D. & Rudensky, A.Y. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat. Immunol. 6, 331-337 (2005).
2. Ramsdell, F. Foxp3 and natural regulatory T cells: Key to a cell lineage? Immunity 19, 165-168 (2003).
3. Brunkow, M.E. et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27, 68-73 (2001).
4. Bennett, C.L. et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27, 20-21 (2001).
5. Wildin, R.S. et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27, 18-20 (2001).
6. Chatila, T.A. et al. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J. Clin. Invest. 106, R75-R81 (2000).
7. Godfrey, V.L., Rouse, B.T. & Wilkinson, J.E. Transplantation of T cell-mediated, lymphoreticular disease from the scurfy (sf) mouse. Am. J. Pathol. 145, 281-286 (1994).
8. + regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6, 345-352 (2005).
9. Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061 (2003).
10. + T regulatory cells. Nat. Immunol. 4, 337-342 (2003).
11. + regulatory T cells. Nat. Immunol. 4, 330-336 (2003).
12. Fontenot, J.D. et al. Regulatory T cell lineage specification by the forkhead transcription factor Foxp3. Immunity 22, 329-341 (2005).
13. Ziegler, S.F. FOXP3: Of mice and men. Annu. Rev. Immunol. 24 209-226 (2006).
14. - T cells. J. Clin. Invest. 112, 1437-1443 (2003).
15. Gavin, M.A. et al. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc. Natl. Acad. Sci. USA 103, 6659-6664 (2006).
16. Oswald-Richter, K. et al. HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. PLoS Biol. 2 E198 (2004).
17. + regulatory T cells. Int. Immunol. 16, 1643-1656 (2004).
18. Williams, L.M. & Rudensky, A.Y. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat. Immunol. 8, 277-284 (2007).
19. Wan, Y.Y. & Flavell, R.A. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc. Natl. Acad. Sci. USA 102, 5126-5131 (2005).
20. Bochtler, P., Wahl, C., Schirmbeck, R. & Reimann, J. Functional adaptive CD4 Foxp3 T cells develop in MHC class II-deficient mice. J. Immunol. 177, 8307-8314 (2006).
21. Bosco, N., Agenes, F., Rolink, A.G. & Ceredig, R. Peripheral T cell lymphopenia and concomitant enrichment in naturally arising regulatory T cells: The case of the pre-Tα gene-deleted mouse. J. Immunol. 177, 5014-5023 (2006).
22. Pennington, D.J. et al. Early events in the thymus affect the balance of effector and regulatory T cells. Nature 444, 1073-1077 (2006).
23. Chang, X. et al. The Scurfy mutation of FoxP3 in the thymus stroma leads to defective thymopoiesis. J. Exp. Med. 202, 1141-1151 (2005).
24. Liston, A. et al. Lack of Foxp3 function and expression in the thymic epithelium. J. Exp. Med. (in the press).
25. + T reg cells impinge on autoimmune diabetes. J. Exp. Med. 202, 1387-1397 (2005).
26. Hsieh, C.S., Zheng, Y., Liang, Y., Fontenot, J.D. & Rudensky, A.Y. An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires. Nat. Immunol. 7, 401-410 (2006).
27. Kim, J.M., Rasmussen, J.P. & Rudensky, A.Y. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8, 191-197 (2007).
28. + regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2, 301-306 (2001).
29. Apostolou, I., Sarukhan, A., Klein, L. & von Boehmer, H. Origin of regulatory T cells with known specificity for antigen. Nat. Immunol. 3, 756-763 (2002).
30. Kim, J.M. & Rudensky, A. The role of the transcription factor Foxp3 in the development of regulatory T cells. Immunol. Rev. 212, 86-98 (2006).
31. Liston, A. & Rudensky, A. Thymic development and peripheral homeostasis of regulatory T cells. Curr. Opin. Immunol. (in the press).
32. + T cell receptors. Immunity 21, 267-277 (2004).
33. Gavin, M.A. et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445, 771-775 (2007).
34. Lin, W. et al. Regulatory T cell development in the absence of functional Foxp3. Nat. Immunol. 8, 359-368 (2007).
35. + regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med. 201, 723-735 (2005).
36. Fontenot, J.D., Rasmussen, J.P., Gavin, M.A. & Rudensky, A.Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6, 1142-1151 (2005).
37. Wan, Y.Y. & Flavell, R.A. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 445, 766-770 (2007).
38. + T cells. Eur. J. Immunol. 37, 129-138 (2007).
39. + T helper cells. Cell 126, 1121-1133 (2006).
40. Schubert, L.A., Jeffery, E., Zhang, Y., Ramsdell, F. & Ziegler, S.F. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J. Biol. Chem. 276, 37672-37679 (2001).
41. Bettelli, E., Dastrange, M. & Oukka, M. Foxp3 interacts with nuclear factor of activated T cells and NF-κB to repress cytokine gene expression and effector functions of T helper cells. Proc. Natl. Acad. Sci. USA 102, 5138-5143 (2005).
42. Grant, C. et al. Foxp3 represses retroviral transcription by targeting both NF-κB and CREB pathways. PLoS Pathog 2, e33 (2006).
43. Lopes, J.E. et al. Analysis of FOXP3 reveals multiple domains required for its function as a transcriptional repressor. J. Immunol. 177, 3133-3142 (2006).
44. Zheng, Y. et al. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445, 936-940 (2007).
45. Chen, C., Rowell, E.A., Thomas, R.M., Hancock, W.W. & Wells, A.D. Transcriptional regulation by Foxp3 is associated with direct promoter occupancy and modulation of histone acetylation. J. Biol. Chem. 281, 36828-36834 (2006).
46. Wu, Y. et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126, 375-387 (2006).
47. Marson, A. et al. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 445, 931-935 (2007).
48. Cobb, B.S. et al. A role for Dicer in immune regulation. J. Exp. Med. 203, 2519-2527 (2006).